Lv11
45 积分 2021-02-22 加入
Discovery of a novel and potent antiplatelet thiol prodrug CG-0255
1小时前
已完结
Neutral LPAR1 Antagonists for the Treatment of Idiopathic Pulmonary Fibrosis
24天前
已完结
Evaluation of an Innovative Population Pharmacokinetic-Based Design for Behavioral Pharmacodynamic Endpoints
1个月前
已完结
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
1个月前
已完结
Venture Capital Investment in Neurology Companies
1个月前
已完结
Design and Synthesis of Clinical Candidate PF-06852231 (CVL-231): A Brain Penetrant, Selective, Positive Allosteric Modulator of the M4 Muscarinic Acetylcholine Receptor
1个月前
已完结
NovelN-Substituted Benzimidazolones as Potent, Selective, CNS-Penetrant, and Orally Active M1mAChR Agonists
1个月前
已完结
Discovery of the Potent and Selective M1 PAM-AgonistN-[(3R,4S)-3-Hydroxytetrahydro-2H-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)benzyl]pyridine-2-carboxamide (PF-06767832): Evaluation of Efficacy and Cholinergic Side Effects
1个月前
已完结
A golden age of muscarinic acetylcholine receptor modulation in neurological diseases
1个月前
已完结
Design and synthesis of N-[6-(Substituted Aminoethylideneamino)-2-Hydroxyindan-1-yl]arylamides as selective and potent muscarinic M1 agonists
1个月前
已完结
皖公网安备34019202002308
